TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)
TWD 7.83
(-13.29%)
TWD 7.83
(-13.29%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.61 Million TWD | -19.14% |
| 2022 | 8.18 Million TWD | 19.47% |
| 2021 | 6.85 Million TWD | -5.87% |
| 2020 | 7.27 Million TWD | -11.38% |
| 2019 | 8.21 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 5.04 Million TWD | 0.0% |
| 2024 Q1 | 5.04 Million TWD | -23.83% |
| 2023 FY | 6.61 Million TWD | -19.14% |
| 2023 Q2 | 4.43 Million TWD | 0.0% |
| 2023 Q1 | 4.43 Million TWD | -45.82% |
| 2023 Q3 | 6.61 Million TWD | 49.22% |
| 2023 Q4 | 6.61 Million TWD | 0.0% |
| 2022 Q4 | 8.18 Million TWD | 0.0% |
| 2022 Q3 | 8.18 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | 5.376% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 98.866% |
| Level Biotechnology Inc. | 273.2 Million TWD | 97.578% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 95.198% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 96.649% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 99.502% |
| GlycoNex Incorporation | 276.39 Million TWD | 97.606% |
| VBI | 21.25 Million TWD | 68.858% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 97.89% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 98.714% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | 68.821% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 98.203% |
| Visgeneer Inc. | 185.6 Million TWD | 96.434% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 99.5% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 99.097% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 94.479% |
| Neith Corporation | 17.43 Million TWD | 62.038% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 99.705% |
| Enimmune corporation | 173.46 Million TWD | 96.185% |
| TaiRx, Inc. | 60.62 Million TWD | 89.084% |
| CHO Pharma, Inc. | 110.83 Million TWD | 94.029% |
| EirGenix Inc. | 1.14 Billion TWD | 99.422% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 94.09% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 98.709% |
| Lin BioScience, Inc. | 167.73 Million TWD | 96.054% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 92.938% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | 89.501% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 94.694% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 95.891% |
| RBC Bioscience Corporation | 513.08 Million TWD | 98.71% |
| BiOptic Inc. | 170.56 Million TWD | 96.12% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | 84.302% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | 71.542% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | 75.318% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 99.321% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | 16.984% |
| NaviFUS Corp. | 53.4 Million TWD | 87.607% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 98.626% |
| Sinew Pharma Inc. | 39.71 Million TWD | 83.336% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | 88.597% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 98.184% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 97.093% |
| AP Biosciences Inc | 106.65 Million TWD | 93.795% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 99.813% |
| 3D Global Biotech Inc. | 30.68 Million TWD | 78.43% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 96.623% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 99.571% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 99.236% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | 28.655% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | 88.143% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 97.159% |
| TCI GENE Inc. | 155.54 Million TWD | 95.745% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | 74.055% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | 85.668% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 97.985% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 89.801% |
| PharmaEngine, Inc. | 91 Million TWD | 92.728% |
| Savior Lifetec Corporation | 457.95 Million TWD | 98.555% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 94.035% |
| OBI Pharma, Inc. | 650.44 Million TWD | 98.983% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 98.307% |
| Acepodia, Inc. | 384.47 Million TWD | 98.279% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 92.264% |